Comparative Evaluation of Efficacy of Dhatriphala and Haritaki in Panduroga

Comparative Evaluation of Efficacy of Dhatriphala(Emblica officinalis gaertn)and Haritaki(Terminalia chebula Retz)in Panduroga w.r.t. Iron Deficiency Anaemia,an open labelled randomised standard controlled clinical trial - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085938

Enrollment

Registered

2025-04-29

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having hemoglobin level between 8 to 10 gm/dl

Exclusion criteria

Exclusion criteria: Age less than 18 years and more than 60 years women.Pregnancy and lactation.Severe Renal/Hepatic/Cardiac diseases and any other condition.Any continuing blood loss.Dimorphic anaemia

Design outcomes

Primary

Measure	Time frame
Significant effect of dhatriphala guda vati in panduroga.Timepoint: 45 days	—

Secondary

Measure	Time frame
Increase in hemoglobin levelTimepoint: 45 days	—

Countries

India

Contacts

Public ContactVd Charusheela Giri

D Y Patil Deemed to be University, School of Ayurveda

charushila.giri@dypatil.edu9892356496

Outcome results